Search Results Search Sort by RelevanceMost Recent History of Medicine Mar 2010 Stigmatization Complicates Infectious Disease Management Phil Perry, MSJ and Fred Donini-Lenhoff, MA Afflicted individuals and racial or national groups have been stigmatized because of perceptions about highly contagious, difficult-to-cure diseases. Virtual Mentor. 2010;12(3):225-230. doi: 10.1001/virtualmentor.2010.12.3.mhst1-1003. Policy Forum Aug 2010 Addressing Gay Men’s Health: The Script Needs a Rewrite Jim Pickett An argument for replacing the disease-centered approach to gay men’s health with a whole-person, wellness approach. Virtual Mentor. 2010;12(8):668-672. doi: 10.1001/virtualmentor.2010.12.8.pfor2-1008. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Current page 11
History of Medicine Mar 2010 Stigmatization Complicates Infectious Disease Management Phil Perry, MSJ and Fred Donini-Lenhoff, MA Afflicted individuals and racial or national groups have been stigmatized because of perceptions about highly contagious, difficult-to-cure diseases. Virtual Mentor. 2010;12(3):225-230. doi: 10.1001/virtualmentor.2010.12.3.mhst1-1003.
Policy Forum Aug 2010 Addressing Gay Men’s Health: The Script Needs a Rewrite Jim Pickett An argument for replacing the disease-centered approach to gay men’s health with a whole-person, wellness approach. Virtual Mentor. 2010;12(8):668-672. doi: 10.1001/virtualmentor.2010.12.8.pfor2-1008.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.